1. Home
  2. ALUR vs COCP Comparison

ALUR vs COCP Comparison

Compare ALUR & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.48

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.02

Market Cap

15.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALUR
COCP
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
15.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALUR
COCP
Price
$1.48
$1.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.25
$6.00
AVG Volume (30 Days)
109.6K
98.5K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,208,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.90
52 Week High
$7.40
$2.67

Technical Indicators

Market Signals
Indicator
ALUR
COCP
Relative Strength Index (RSI) 46.97 45.06
Support Level $1.28 $1.00
Resistance Level $1.57 $1.19
Average True Range (ATR) 0.16 0.06
MACD -0.03 -0.01
Stochastic Oscillator 33.08 9.09

Price Performance

Historical Comparison
ALUR
COCP

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: